SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | 0.0% | 115 | -14.8% | 0.00% | – |
Q4 2021 | $4,000 | -86.2% | 135 | -88.9% | 0.00% | -100.0% |
Q2 2020 | $29,000 | +625.0% | 1,215 | +631.9% | 0.00% | +200.0% |
Q4 2019 | $4,000 | -92.9% | 166 | -90.2% | 0.00% | -93.3% |
Q2 2019 | $56,000 | +300.0% | 1,692 | +324.1% | 0.02% | +150.0% |
Q1 2019 | $14,000 | +1300.0% | 399 | +1230.0% | 0.01% | – |
Q4 2018 | $1,000 | -50.0% | 30 | -6.2% | 0.00% | -100.0% |
Q2 2018 | $2,000 | -81.8% | 32 | -88.7% | 0.00% | -87.5% |
Q4 2017 | $11,000 | +10.0% | 284 | -27.0% | 0.01% | -20.0% |
Q4 2016 | $10,000 | – | 389 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |